DOI QR코드

DOI QR Code

Investigation of Antibody Titers after Inoculation with Commercial Equine Influenza Vaccines in Thoroughbred Yearlings

Thoroughbred 1세말에서 상업용 말 인플루엔자 백신접종 후 항체역가 추적

  • Yang, J.H. (Korea National College of Agriculture and Fisheries) ;
  • Park, Y.S. (Korea National College of Agriculture and Fisheries)
  • 양재혁 (한국농수산대학 말산업학과) ;
  • 박용수 (한국농수산대학 말산업학과)
  • Published : 2018.06.30

Abstract

The object of this study was to evaluate the change of antibody titers on virus strains after inoculation with commercial killed equine influenza (EI) vaccines in horses. Serum antibodies of 20 Thoroughbred yearlings were detected using hemagglutination inhibition test for 41 weeks. Second vaccination is inoculated 4 weeks after the initial vaccination. Most of antibody titers were not increased until 4 weeks after first vaccination. The highest titers were detected 6-10 weeks after vaccination. The titers were decreased slowly and maintained for 16 weeks after inoculation. We could barely detect the antibody 41 weeks after vaccination in most cases. Vaccine anergia were appeared in 3 horses (15%) but it depended on virus strains. A/Equine/La Plata/93(H3N8) strain that induce high and durable antibody responses was the most effective among three strains. This study presents the first comprehensive data on the endurance of antibody titers against EI. Our data also suggests that yearlings should be inoculated three times in order to maintaining optimal antibody titers against EI. We speculate the causes of anergia were vaccine break down or individual specificity. Further research is needed to investigate immunological unresponsiveness. This was the first study on strain of equine vaccine in Korea.

말인플루엔자(EI) 사독백신 투여 후 virus strains 별로 항체역가 변화를 측정하였다. 더러브렛말(1세) 20마리에서 혈구응집억제반응법으로 혈청항체를 41주 동안 관찰하였다. 기초접종 4주 후에 2차접종을 하였다. 그러나 2차 접종 직전의 혈청에서는 대부분 항체역가가 관찰되지 않았다. 역가 최고치는 접종 후 6-10주였고, 16주 동안 유지되었으며 이후 서서히 감소하였다. 백신무반응은 3마리(15%) 말에서 나타났지만 이는 virus strains에 좌우되었다. A/Equine/La Plata/93(H3N8)는 3개의 strain 중에서 높고 안정적인 항체반응을 유도하였다. 결과를 바탕으로 항체역가를 유지하기 위해서는 1세마에 3회 접종이 권고된다. 저자들은 백신에 대한 무반응은 백신브레이크 또는 개체특이성에 기인하였다고 추측하였다. 이 실험은 국내 최초의 EI 백신 strain에 대한 연구였으며 면역학적 무반응에 대해서는 추가 연구가 필요하다.

Keywords

Acknowledgement

모든 자료는 한국마사회의 허가를 득하였으며 특히, 본 연구에 혈청역가 검정실험을 맡아주신 한국마사회 양선주 선생님께 감사드립니다.

References

  1. Ainsworth, D. M. and J. Cheetham. (2010). Disorders of the respiratory system. In: Reed, S. M., W. M. Bayly, D. C. Sellon, eds, Equine internal medicine, 3rded. Saunders. pp. 311-313.
  2. Daly, J. M., S. MacRae, J. R. Newton, E. Wattrang and D. M. Elton. (2011). Equine influenza: a review of an unpredictable virus. Vet J 189: 7-14.
  3. Daly, J. M., J. R. Newton and J. A. Mumford. (2004). Current perspectives on control of equine influenza. Vet Res 35: 411-423.
  4. Daly, J. M., T. Sindle, J. Tearle, N. Barquero, J. R. Newton and S. Corning. (2007). Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa /4/03 (H3N8) strain in a short-term vaccine efficacy study. Equine Vet J 39: 446-450.
  5. Daly, J. M., P. J. Yates, J. R. Newton, A. Park, W. Henley, J. L. Wood, N. DavisPoynter and J. A. Mumford. (2004). Evidence supporting the inclusion of strains from each of the two cocirculating lineages of H3N8 equine influenza virus in vaccines. Vaccine 28: 4101-4109.
  6. Hannant, D., J. A. Mumford and D. M. Jessett. (1988). Duration of circulating antibody and immunity following infection with equine influenza virus. Vet Rec 122: 125-128.
  7. Hsiung, G. D. (1973). Diagnostic virologyAn illustrated handbook. 1sted. Yale University Press. pp.26-34.
  8. Knottenbelt, D. and R. Pascoe. (2003). Routine stud management procedures. In: Knottenbelt, D., R. Pascoe, C. L. Lopate, M. M. LeBlanc, eds, Equine stud medicine and surgery, 1sted. Saunders. pp. 25-41.
  9. Korean Veterinary Medical Association. (2008). The history of Korean Veterinary 60 years. KVMA. pp. 754-755.
  10. Landolt, G. A., H. G. G. Townsend and D. P. Lunn. (2007). Equine Influenza Infection. In: Sellon, D. C., Long, M. T. eds, Equine Infectious Disease, 1sted. Saunders. pp. 124-134.
  11. Morley, P. S., H. G. Townsend, J. R. Bogdan and D. M. Haines. (1999). Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses. J Am Vet Med Assoc 215: 61-66.
  12. Mumford, J. A., D. Jessett, U. Dunleavy, J. Wood, D. Hannant, B. Sundquist and R. F. Cook. (1994). Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. Vaccine 12: 857-863.
  13. Mumford, J. A., H. Wilson, D. Hannant and D. M. Jessett. (1994). Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiol Infect 112: 421-437.
  14. Newton, J. R., H. G. Townsend, J. L. Wood, R. Sinclair, D. Hannant and J. A. Mumford. (2000). Immunity to equine influenza: relationship of vaccineinduced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Vet J 32: 65-74.
  15. Paillot, R., D. Hannant, J. H. Kydd and J. M. Daly. (2006). Vaccination against equine influenza: quid novi? Vaccine 24: 4047-4061.
  16. Paillot, R., L. Prowse, C. Donald, E. Medcalf, F. Montesso, N. Bryant, J. Watson, M. Jeggo, D. Elton, R. Newton, P. Trail and H. I. Barnes. (2010). Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding. Vet Immunol Immunopathol 136:272-283.
  17. Slater, J. and D. Hannant. (2000). Equine immunity to viruses. Vet Clin North Am Equine Pract 16: 49-68.
  18. Soboll, G., D. W. Horohov, B. M. Aldridge, C. W. Olsen, M. W. McGregor, R. J. Drape, M. D.Macklin, W. F. Swain and D. P. Lunn. (2003). Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination. Vet Immunol Immunopathol 94: 47-62.
  19. Traub-Dargatz, J. L., M. D. Salman and J. L. Voss. (1991). Medical problems of adult horses, as ranked by equine practitioners. J Am Vet Med Assoc 198: 1745-1747.
  20. Webster, R. G., W. J. Bean, O. T. Gorman, T. M. Chambers and Y. Kawaoka. (1992). Evolution and ecology of influenza A viruses. Microbiol Rev 56: 152-179.
  21. Webster, W. R. (2011). Overview of the 2007 Australian outbreak of equine influenza. Aust Vet J 89: 3-4.
  22. Wood, J., K. C. Smith, J. M. Daly and J. R. Newton. (2007). Viral infectious of the equine respiratory track. In: McGorum, B. C., P. M. Dixon, N. E. Robinson, J. Schumacher, eds, Equine respiratory medicine and surgery, 1sted. Saunders. pp. 287-297.